The MIT Center for Integrative Synthetic Biology will create the therapeutics of the future by integrating systems biology and synthetic biology. Systems biology, synthetic biology, and fundamental research in health-related applications are three major disciplines that have thrived in the last decade. These fields have pushed the frontiers of biomedical science with the development of high-throughput platforms for generating and analyzing systems-level data, unprecedented abilities to engineer biological systems, and significant advances in our understanding of the molecular mechanisms underlying human disease. However, due to the diverse expertise required in each discipline, these efforts have been largely independent from each other. Therefore there is a significant opportunity for the integration of systems biology, synthetic biology, and health-related applications in a single research center. Our core group of researchers at MIT is poised to spearhead efforts to overcome these challenges with the MIT Center for Integrative Synthetic Biology. A key feature of the proposed Center is our focus on interdisciplinary and collaborative research into next-generation therapeutics. Our major disease-related targets revolve around Cancer, Diabetes, and Infectious Diseases. Together systems biology and synthetic biology will contribute to significant advances in health-related applications. By integrating top-down systems views of disease with bottom-up synthetic construction of novel treatments, this community will create new disease therapies with the ability to integrate multiple inputs and deliver specific interventions. Numerous synergies in synthetic biology, systems biology, and health-related applications will be generated by the MIT Center for Integrated Synthetic Biology which would be difficult to achieve via solely independent investigator-led research efforts.
Next-generation therapeutics for important diseases constitute the central thrusts of the MIT Center for Integrative Synthetic Biology. Our target areas include Cancer, Diabetes, and Infectious Diseases. All research efforts in the Center will be integrated into these three disease thrusts, which will bring together an interdisciplinary team of systems biologists, synthetic biologists, biomedical researchers, and clinicians.
|Farzadfard, Fahim; Lu, Timothy K (2014) Synthetic biology. Genomically encoded analog memory with precise in vivo DNA writing in living cell populations. Science 346:1256272|
|Mishra, Deepak; Rivera, Phillip M; Lin, Allen et al. (2014) A load driver device for engineering modularity in biological networks. Nat Biotechnol 32:1268-75|
|Citorik, Robert J; Mimee, Mark; Lu, Timothy K (2014) Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases. Nat Biotechnol 32:1141-5|
|Brophy, Jennifer A N; Voigt, Christopher A (2014) Principles of genetic circuit design. Nat Methods 11:508-20|
|Citorik, Robert J; Mimee, Mark; Lu, Timothy K (2014) Bacteriophage-based synthetic biology for the study of infectious diseases. Curr Opin Microbiol 19:59-69|
|Roquet, Nathaniel; Lu, Timothy K (2014) Digital and analog gene circuits for biotechnology. Biotechnol J 9:597-608|
|Nissim, Lior; Perli, Samuel D; Fridkin, Alexandra et al. (2014) Multiplexed and programmable regulation of gene networks with an integrated RNA and CRISPR/Cas toolkit in human cells. Mol Cell 54:698-710|
|Yang, Lei; Nielsen, Alec A K; Fernandez-Rodriguez, Jesus et al. (2014) Permanent genetic memory with >1-byte capacity. Nat Methods 11:1261-6|
|Kiani, Samira; Beal, Jacob; Ebrahimkhani, Mohammad R et al. (2014) CRISPR transcriptional repression devices and layered circuits in mammalian cells. Nat Methods 11:723-6|
|Purcell, Oliver; Lu, Timothy K (2014) Synthetic analog and digital circuits for cellular computation and memory. Curr Opin Biotechnol 29:146-55|